Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL)
| Assets | $14.78M |
| NAV | $12.32 |
| Expense Ratio | 0.97% |
| PE Ratio | n/a |
| Shares Out | 1.20M |
| Dividend (ttm) | $0.01 |
| Dividend Yield | 0.10% |
| Ex-Dividend Date | Jun 22, 2022 |
| 1-Year Return | -42.10% |
| Volume | 30,040 |
| Open | 12.14 |
| Previous Close | 12.33 |
| Day's Range | 11.71 - 12.47 |
| 52-Week Low | 8.05 |
| 52-Week High | 23.69 |
| Beta | 2.59 |
| Holdings | 50 |
| Inception Date | Nov 15, 2017 |
About PILL
The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.
Top 10 Holdings
717081407.86% of assets| Name | Symbol | Weight |
|---|---|---|
| Pfizer | PFE | 717,081,103.00% |
| S&P PHARMACEUTICALS SELECT INDEX SWAP | n/a | 88.58% |
| S&P PHARMACEUTICALS SELECT INDEX SWAP | n/a | 86.18% |
| S&P PHARMACEUTICALS SELECT INDEX SWAP | n/a | 78.99% |
| DREYFUS GOVT CASH MGMT | n/a | 18.39% |
| GOLDMAN FINL SQ TRSRY INST 506 | n/a | 16.53% |
| GOLDMAN FS GOVT INST | n/a | 6.15% |
| DREYFUS GOVT CASH MGMT | n/a | 5.42% |
| Axsome Therapeutics | AXSM | 2.53% |
| Nektar Therapeutics | NKTR | 2.08% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 22, 2022 | $0.00361 | Jun 29, 2022 |
| Mar 22, 2022 | $0.00817 | Mar 29, 2022 |
| Dec 21, 2021 | $0.00007 | Dec 29, 2021 |
| Dec 23, 2019 | $0.00033 | Dec 31, 2019 |
| Sep 24, 2019 | $0.01521 | Oct 1, 2019 |
| Jun 25, 2019 | $0.02237 | Jul 2, 2019 |
News
3 ETFs to Access a Changing Pharmaceutical Industry
A changing pharmaceutical industry is setting up a few trades in the leveraged fund space, specifically for ETFs from Direxion Investments. One of the catalysts for change, especially within the past ye...
5 Best Leverage ETF Areas to Watch as Markets Bounces Back
Wall Street started the week on a shaky note due to a spike in U.S. COVID cases, which is a potential threat to economic reopening.
4 Best Leveraged ETFs of Last Week
Wall Street was moderate last week as rising rate concerns weighed on the stocks occasionally.
3 Pharmaceutical ETFs That Could Be Due For A Rebound
These three pharmaceutical ETFs have dropped to support, which means they may be about to rebound. Support is a large concentration of buyers who have gathered around the same price level.
PILL Hasn't Been a Bitter ETF to Swallow The Past Month
The Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (PILL) is up about 20% the past month, which is making it an easy pill to swallow for traders looking to capitalize on this sub-sector of h...
3 Leveraged Healthcare ETFs Soaring This Month
The new coronavirus from China has claimed more than 800 lives and there are now more than 37,000 documented cases of the respiratory illness worldwide, making it more deadly than the 2003 SARS epidemic.
7 ETFS That May Not Make It Through 2020
Forecasting the next funds to hit the ETF graveyard can be tricky as the decision to hit the “off” switch lies with the issuer, but a combination of low assets and weak volume usually is widely viewed a...
5 Leveraged ETFs That Gained More Than 20% in October
We have highlighted five leveraged equity ETFs that piled up more than 20% returns in October and could continue to be investors' darlings.
With Earnings On Tap, A Stir In This Leveraged Pharmaceuticals ETF
With pharmaceuticals stocks under intense political scrutiny this year, the Dynamic Pharmaceutical Intellidex Index (DZRTR) is lower by nearly 8% and is on pace for one of its worst annual performances ...